Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
2 hedge funds and large institutions have $4K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.19K |
Top Sellers
PHIOW Hedge Fund Activity: Q2 2020 in Review
2 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q2 2020, worth a combined $4K.
Fund positioning in PHIOW was balanced in Q2 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.19K.
- 2 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $4K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q2 2020.
- 1 fund opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q2 2020 and 1 closed out, a net change of 0 holders.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q2 2020 was Susquehanna International Group, an estimated $2.19K added.
Based on aggregated 13F filings for Q2 2020.